Thomas A. McCourt
Chief Commercial Officer, Ironwood Pharmaceuticals.
Companies
- Pliant (United States)Board member Mar 8, 2023 to now1
- Ironwood PharmaceuticalsBoard member Jun 9, 2021 to now2
- Ironwood PharmaceuticalsChief executive officer Mar 30, 2021 to now3
- Acceleron PharmaBoard member Jul 25, 2016 to Nov 22, 20214
- Ironwood PharmaceuticalsPresident Apr 3, 2019 to May 26, 20215
- Ironwood PharmaceuticalsChief Commercial Officer Feb 2, 2010 to Feb 22, 20196
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ironwood Pharmaceuticals IRWD1,898,838 shares7$7.2M at $3.77Mar 10, 2026
- Acceleron Pharma XLRN0 shares8Nov 19, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 10, 2026Granted 409,836 shares of Ironwood Pharmaceuticals7
- Feb 24, 2026Sold 103,526 shares at $3.66 of Ironwood Pharmaceuticals9
- Feb 23, 2026Sold 94,757 shares at $3.81 of Ironwood Pharmaceuticals9
- May 20, 2025Granted 540,000 shares of Ironwood Pharmaceuticals10
- May 16, 2025Sold 13,353 shares at $0.58 of Ironwood Pharmaceuticals10
- Feb 10, 2025Sold 139,064 shares at $1.76 of Ironwood Pharmaceuticals11
- Jan 17, 2025Granted 147,354 shares of Ironwood Pharmaceuticals12
- May 20, 2024Sold 67,618 shares at $6.45 of Ironwood Pharmaceuticals13
- Mar 8, 2024Exercised options 120,298 shares of Ironwood Pharmaceuticals14
- Mar 5, 2024Granted 264,876 shares of Ironwood Pharmaceuticals15
- Feb 12, 2024Sold 177,164 shares at $15.24 of Ironwood Pharmaceuticals16
- Jan 17, 2024Granted 249,617 shares of Ironwood Pharmaceuticals17
- May 30, 2023Sold 26,632 shares at $10.70 of Ironwood Pharmaceuticals18
- May 22, 2023Sold 36,000 shares at $10.12 of Ironwood Pharmaceuticals19
- May 8, 2023Sold 21,148 shares at $10.62 of Ironwood Pharmaceuticals20
- Mar 27, 2023Sold 46,129 shares at $10.67 of Ironwood Pharmaceuticals21
- Mar 8, 2023Granted 240,595 shares of Ironwood Pharmaceuticals22
- Mar 3, 2023Sold 33,756 shares at $11.22 of Ironwood Pharmaceuticals23
- Feb 28, 2023Sold 4,588 shares at $11.31 of Ironwood Pharmaceuticals24
- Feb 28, 2023Sold 26,639 shares at $11.31 of Ironwood Pharmaceuticals24
- Feb 27, 2023Sold 4,409 shares at $11.41 of Ironwood Pharmaceuticals24
- Feb 27, 2023Sold 25,595 shares at $11.41 of Ironwood Pharmaceuticals24
- Jan 17, 2023Granted 30,145 shares of Ironwood Pharmaceuticals25
- Jan 5, 2023Sold 110,962 shares at $12.07 of Ironwood Pharmaceuticals26
- Jan 5, 2023Exercised options 110,962 shares at $11.65 of Ironwood Pharmaceuticals26
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPliant (United States), Board member
- 2
- 3
- 4SEC EDGARAcceleron Pharma, Board member
- 5SEC EDGARIronwood Pharmaceuticals, President
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Feb 25, 2026
- 10SEC EDGARForm 4 filed May 20, 2025
- 11SEC EDGARForm 4 filed Feb 12, 2025
- 12SEC EDGARForm 4 filed Jan 22, 2025
- 13SEC EDGARForm 4 filed May 22, 2024
- 14SEC EDGARForm 4 filed Mar 12, 2024
- 15SEC EDGARForm 4 filed Mar 7, 2024
- 16SEC EDGARForm 4 filed Feb 14, 2024
- 17SEC EDGARForm 4 filed Jan 19, 2024
- 18SEC EDGARForm 4 filed Jun 1, 2023
- 19SEC EDGARForm 4 filed May 24, 2023
- 20SEC EDGARForm 4 filed May 10, 2023
- 21SEC EDGARForm 4 filed Mar 29, 2023
- 22SEC EDGARForm 4 filed Mar 10, 2023
- 23SEC EDGARForm 4 filed Mar 7, 2023
- 24SEC EDGARForm 4 filed Mar 1, 2023
- 25SEC EDGARForm 4 filed Jan 19, 2023
- 26SEC EDGARForm 4 filed Jan 9, 2023